Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
about
Androgen Receptor Signaling in Salivary Gland Cancer.Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms.Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.Submandibular gland cancer: Specific features and treatment considerations.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management.Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas.Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.
P2860
Q37676074-AF011056-4839-43A6-8D2C-6B16B83CA71BQ38377890-193B89A7-46EF-4484-B788-58A0A08E5D7DQ38614842-BD093090-FF7D-452F-8BE8-8FEEFBC6D768Q39012625-7EB61730-9CF7-45C2-AC12-65EE9B8296FAQ39831543-00F1F741-36EB-40C8-8C72-2820F5F699E8Q41708696-8C1D261D-BA34-42EB-9C22-2637E4BC6465Q45987424-1B38F38A-ABAB-47E8-919C-23A81A88D96DQ47133482-3FDAC82C-6088-4CC0-957F-A34E986606A5Q47859326-F33F801B-CC61-4675-9519-0A040E98C6F0Q48123633-A95463CB-FDEF-4108-B454-33CCB0868502Q48236697-110045A1-0AAA-446E-AE81-5734A0419304Q49688722-49FF8564-9AAE-4765-B88D-BED1DAC04135Q51734012-46610A87-A2A4-41F5-B31E-F3FE929A1856
P2860
Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@en
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@nl
type
label
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@en
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@nl
prefLabel
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@en
Salivary duct carcinoma: Clini ...... ectrum, and somatic mutations.
@nl
P2093
P2860
P50
P356
P1433
P1476
Salivary duct carcinoma: Clini ...... pectrum, and somatic mutations
@en
P2093
Christina I Selinger
Jared D Weston
Jonathan R Clark
Rafael Ekmejian
Sandra A O'Toole
Timothy J Eviston
P2860
P304
P356
10.1002/HED.24332
P478
38 Suppl 1
P577
2015-12-24T00:00:00Z